Currently, the stock is revolving around Rs 164 levels and a market investor can take a buy position in the stock for a target price of Rs 244.
Company management has announced Rs 8bn capex plan to be undertaken in a phased manner over the next five years to build capacity in formulations, technical and intermediates for technicals. Photo source: Reuters